ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

Congress Holds Recision Hearings

February 28, 1975

DCT Advisors OK 2 Grant Programs, Disapprove One, In NCI Effort To Improve Funding For Clinical Research

March 8, 1991

Voluntary Organizations: Myles Cunningham elected ACS President

November 8, 1996

Urgent Need For New Drugs To Treat Pre-Cancers: AACR.

March 1, 2002

NCI Programs: Unequal Outcomes For Minorities The Result of Unequal Treatment NCI Suggests Awareness Campaign

December 17, 1999

Cyramza-Docetaxel Combination Extends OS In Second-Line NSCLC

June 27, 2014